Govt Waives Re-labelling of Medicines After GST Cut
Pharmaceutical companies will not have to recall or re-label medicines already available in the market before September 22, 2025, despite…
National Pharmaceutical Pricing Authority
Read More
CDSCO Grants 3-Month Period for Medical Device Firms to Revise MRP Amid GST Rate Cut
The Central Drugs Standard Control Organisation (CDSCO) on Thursday (September 11) directed medical device manufacturers and importers to update their…
Cardiac Stent Prices to Rise by 2% Following Regulator’s Approval
The cost of cardiac stents in India is set to increase by nearly 2% after the country’s drug pricing regulator…